| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adolescent dietary fiber, vegetable fat, vegetable protein, and nut intakes and breast cancer risk
|
Liu, Ying
|
|
2014
|
145 |
2 |
p. 461-470
|
artikel
|
| 2 |
Androgenic pathways in the progression of triple-negative breast carcinoma: a comparison between aggressive and non-aggressive subtypes
|
McNamara, Keely M.
|
|
2014
|
145 |
2 |
p. 281-293
|
artikel
|
| 3 |
A phase IIa, nonrandomized study of radium-223 dichloride in advanced breast cancer patients with bone-dominant disease
|
Coleman, Robert
|
|
2014
|
145 |
2 |
p. 411-418
|
artikel
|
| 4 |
A randomized, placebo-controlled trial of melatonin on breast cancer survivors: impact on sleep, mood, and hot flashes
|
Chen, Wendy Y.
|
|
2014
|
145 |
2 |
p. 381-388
|
artikel
|
| 5 |
Associations between anthropometric characteristics, physical activity, and breast cancer risk in a Canadian cohort
|
Catsburg, Chelsea
|
|
2014
|
145 |
2 |
p. 545-552
|
artikel
|
| 6 |
Birth size in the most recent pregnancy and maternal mortality in premenopausal breast cancer by tumor characteristics
|
Hajiebrahimi, Mohammadhossein
|
|
2014
|
145 |
2 |
p. 471-480
|
artikel
|
| 7 |
Characterization of breast cancers with PI3K mutations in an academic practice setting using SNaPshot profiling
|
Abramson, Vandana G.
|
|
2014
|
145 |
2 |
p. 389-399
|
artikel
|
| 8 |
Clinical and molecular characterization of the BRCA2 p.Asn3124Ile variant reveals substantial evidence for pathogenic significance
|
Surowy, Harald Martin
|
|
2014
|
145 |
2 |
p. 451-460
|
artikel
|
| 9 |
Contributors to nonadherence and nonpersistence with endocrine therapy in breast cancer survivors recruited from an online research registry
|
Stanton, Annette L.
|
|
2014
|
145 |
2 |
p. 525-534
|
artikel
|
| 10 |
Cost-effectiveness analysis of extended adjuvant endocrine therapy in the treatment of post-menopausal women with hormone receptor positive breast cancer
|
Erman, Aysegul
|
|
2014
|
145 |
2 |
p. 267-279
|
artikel
|
| 11 |
Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations
|
Sokolenko, Anna P.
|
|
2014
|
145 |
2 |
p. 553-562
|
artikel
|
| 12 |
Epithelial mesenchymal transition in early invasive breast cancer: an immunohistochemical and reverse phase protein array study
|
Aleskandarany, Mohammed A.
|
|
2014
|
145 |
2 |
p. 339-348
|
artikel
|
| 13 |
Erratum to: Fatal breast cancer risk in relation to use of unopposed estrogen and combined hormone therapy
|
Pocobelli, Gaia
|
|
2014
|
145 |
2 |
p. 449
|
artikel
|
| 14 |
Fatal breast cancer risk in relation to use of unopposed estrogen and combined hormone therapy
|
Pocobelli, Gaia
|
|
2014
|
145 |
2 |
p. 439-447
|
artikel
|
| 15 |
Folate intake and the risk of breast cancer: a systematic review and meta-analysis
|
Tio, Martin
|
|
2014
|
145 |
2 |
p. 513-524
|
artikel
|
| 16 |
Letter in response: breast cancer screening of women aged 70–74 years
|
Burton, Robert
|
|
2014
|
145 |
2 |
p. 563-564
|
artikel
|
| 17 |
Patterns of chemotherapy, toxicity, and short-term outcomes for older women receiving adjuvant trastuzumab-based therapy
|
Freedman, Rachel A.
|
|
2014
|
145 |
2 |
p. 491-501
|
artikel
|
| 18 |
Prognostic and biological significance of proliferation and HER2 expression in the luminal class of breast cancer
|
Jerjees, Dena A.
|
|
2014
|
145 |
2 |
p. 317-330
|
artikel
|
| 19 |
Prognostic factors for survival in metastatic breast cancer by hormone receptor status
|
Kwast, A. B. G.
|
|
2014
|
145 |
2 |
p. 503-511
|
artikel
|
| 20 |
Prognostic relevance of glycosylation-associated genes in breast cancer
|
Milde-Langosch, Karin
|
|
2014
|
145 |
2 |
p. 295-305
|
artikel
|
| 21 |
Randomized phase II study of weekly paclitaxel with and without carboplatin followed by cyclophosphamide/epirubicin/5-fluorouracil as neoadjuvant chemotherapy for stage II/IIIA breast cancer without HER2 overexpression
|
Ando, Masashi
|
|
2014
|
145 |
2 |
p. 401-409
|
artikel
|
| 22 |
RANK expression as a prognostic and predictive marker in breast cancer
|
Pfitzner, Berit Maria
|
|
2014
|
145 |
2 |
p. 307-315
|
artikel
|
| 23 |
Re-attendance at biennial screening mammography following a repeated false positive recall
|
Klompenhouwer, Elisabeth G.
|
|
2014
|
145 |
2 |
p. 429-437
|
artikel
|
| 24 |
Rebuttal to: Letter to the Editor by Robert Burton, in response to doi:10.1007/s10549-013-2794-5
|
Nickson, Carolyn
|
|
2014
|
145 |
2 |
p. 565-566
|
artikel
|
| 25 |
Regulation of apoptosis by long non-coding RNA GAS5 in breast cancer cells: implications for chemotherapy
|
Pickard, Mark R.
|
|
2014
|
145 |
2 |
p. 359-370
|
artikel
|
| 26 |
Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort
|
Fournier, Agnès
|
|
2014
|
145 |
2 |
p. 535-543
|
artikel
|
| 27 |
Surgical excision of radial scars diagnosed by core biopsy may help predict future risk of breast cancer
|
Miller, Cynthia L.
|
|
2014
|
145 |
2 |
p. 331-338
|
artikel
|
| 28 |
Tamoxifen-associated hot flash severity is inversely correlated with endoxifen concentration and CYP3A4*22
|
Baxter, Simon D.
|
|
2014
|
145 |
2 |
p. 419-428
|
artikel
|
| 29 |
The endoplasmic reticulum stress markers GRP78 and CHOP predict disease-free survival and responsiveness to chemotherapy in breast cancer
|
Zheng, Yi-Zi
|
|
2014
|
145 |
2 |
p. 349-358
|
artikel
|
| 30 |
Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor®) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study
|
Donders, Gilbert
|
|
2014
|
145 |
2 |
p. 371-379
|
artikel
|
| 31 |
Use of menopausal hormone therapy and risk of ductal and lobular breast cancer among women 55–74 years of age
|
Li, Christopher I.
|
|
2014
|
145 |
2 |
p. 481-489
|
artikel
|
Tijdschrift beschrijving